RxCelerate Email Format

Biotechnology ResearchEngland, United Kingdom51-200 Employees

RxCelerate Limited provides end-to-end drug discovery and development services across Europe and the United States. Its offering combines computational modelling, medicinal chemistry, in vitro and preclinical biology, and project management to help clients advance candidates efficiently. Headquartered in Babraham, Cambridgeshire, RxCelerate collaborates with sister companies RxBiologics and The Cambridge Partnership to provide integrated support across small-molecule and biologic programs.

In March 2026, the company announced the launch of RxPlorer, a platform designed to identify small-molecule hits against challenging, previously undruggable targets, expanding its discovery toolkit. The organization emphasizes a people-first culture that supports collaboration, development, and inclusivity for its employees. Through combined scientific execution and back-office support, it addresses the needs of customers pursuing both small molecules and biologics to move assets forward.

Sign up for free to view info

Company overview Employee directory